COMMUNIQUÉS West-GlobeNewswire

Amended News Release - Aspri Pharma Canada Inc. Announces Acquisition of Subordinate Voting Shares of Devonian Health Group Inc.

07/02/2018 - 15:57

CONCORD, Ontario, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Aspri Pharma Canada Inc. (“ Aspri ), a pharmaceutical products wholesale and manufacturer corporation, announces that on February 1, 2018, Devonian Health Group Inc [...]

Tyme Provides Clinical and Corporate Update for Fiscal Third Quarter 2017

07/02/2018 - 15:44

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced a clinical and corporate update for the fiscal [...]

Auris Medical Reports New Data Highlighting Superior Bioavailability of AM-125 Compared to Oral Betahistine

07/02/2018 - 15:11

Single dose animal study demonstrates 5 to 35 times higher bioavailability of intranasal betahistine relative to oral betahistine Bioavailability of intranasal betahistine in humans estimated to be 20 to 40 times higher [...]

Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering

07/02/2018 - 15:00

- Record date established as February 14, 2018 - To be a shareholder of record, investors are advised to own Actinium stock by 4:00 PM ET, Monday, February 12, 2018 to account for T+2 settlement timing - Actinium’s [...]

Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

07/02/2018 - 14:45

First-in-man AAV9-based gene therapy delivered by single intravenous injection targeting central nervous system and peripheral manifestations of MPS IIIB. ABO-101 is well tolerated and demonstrates early biopotency [...]

Advanced Proteome Therapeutics and ImmunoBiochem Corporation enter into a Collaboration and Option Agreement

07/02/2018 - 14:30

VANCOUVER, British Columbia and TORONTO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (APC), a therapeutics discovery and development company, and ImmunoBiochem Corporation, today [...]

BriaCell to Attend 20th Annual BIO CEO & Investor Conference

07/02/2018 - 14:30

BERKELEY, Calif. and VANCOUVER, British Columbia, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]

EyeGate to Present at the 2018 BIO CEO & Investor Conference

07/02/2018 - 14:30

WALTHAM, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG ) (“EyeGate” or the “Company”), a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies [...]

Dyadic International, Inc. Announces Research and Development Collaboration To Produce An Active Ingredient in C1

07/02/2018 - 14:30

JUPITER, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform [...]

Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma

07/02/2018 - 14:15

MADISON, Wis., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB ), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment [...]

Catalyst Pharmaceuticals to Present at Two Upcoming Investor Conferences

07/02/2018 - 14:03

CORAL GABLES, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX ), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Achaogen to Present at the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 14:01

-- Company presentation scheduled for February 15, 2018 at 9:30 a.m. ET -- SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing [...]

Orlando Area Plastic Surgeon Jon Paul Trevisani, MD Voted "Doctor of the Year" by Readers of Orlando Style Magazine

07/02/2018 - 14:01

ORLANDO, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Dr. Jon Paul Trevisani, a board-certified plastic surgeon in Orlando and the founder of the Aesthetic Surgery Center, is Orlando Style Magazine ’s most recent “Doctor of [...]

Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2017 Financial Results Conference Call and Webcast

07/02/2018 - 14:00

CAMBRIDGE, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, will release its [...]

HTG Molecular Diagnostics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference

07/02/2018 - 14:00

TUCSON, Ariz., Feb. 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM ) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced that [...]

SonarMed Announces Adoption of AirWave™ by Two New Institutions

07/02/2018 - 14:00

CARMEL, Ind., Feb. 07, 2018 (GLOBE NEWSWIRE) -- SonarMed today announced the adoption of the AirWave™ Monitoring System for NICU patients by two leading children’s hospitals in California as part of the Company’s [...]

Intra-Cellular Therapies to Present at Upcoming Investor Conferences

07/02/2018 - 14:00

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

BeyondSpring to Present at Upcoming Investor Conferences

07/02/2018 - 14:00

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI ), a global clinical-stage biopharmaceutical company focused on the development of transforming immuno-oncology cancer therapies, today [...]

Caladrius Biosciences to Present at the 2018 BIO CEO & Investor Conference

07/02/2018 - 14:00

BASKING RIDGE, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]